Randomized, double-blind, clinical trial of a polyvalent melanoma vaccine in patients with stage III melanoma.

被引：0
|
作者：
Bystryn, JC
Oratz, R
Shapiro, R
Harris, M
Roses, D
Jacquotte, A
机构：
[1] Kaplan Comprehens Canc Ctr, New York, NY USA
[2] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA
[3] NYU, Sch Med, Dept Med, New York, NY USA
[4] NYU, Sch Med, Dept Surg, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1998年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：498 / 498
页数：1
相关论文
共 50 条
  • [41] Evaluation of Atorvastatin for the Treatment of Patients With Asthma: A Double-Blind Randomized Clinical Trial
    Moini, Abdollatif
    Azimi, Ghasem
    Farivar, Abdolhay
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2012, 4 (05) : 290 - 294
  • [42] IMPROVED SURVIVAL OF PATIENTS WITH MELANOMA WITH AN ANTIBODY-RESPONSE TO IMMUNIZATION TO A POLYVALENT MELANOMA VACCINE
    MILLER, K
    ABELES, G
    ORATZ, R
    ZELENIUCHJACQUOTTE, A
    CUI, J
    ROSES, DF
    HARRIS, MN
    BYSTRYN, JC
    CANCER, 1995, 75 (02) : 495 - 502
  • [43] Are antibiotics beneficial for patients with sinusitis complaints? - A randomized double-blind clinical trial
    Merenstein, D
    Whittaker, C
    Chadwell, T
    Wegner, B
    D'Amico, F
    JOURNAL OF FAMILY PRACTICE, 2005, 54 (02): : 144 - 151
  • [44] A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months
    Vesikari, Timo
    Becker, Thomas
    Vertruyen, Andre F.
    Poschet, Katleen
    Flores, Sheryl A.
    Pagnoni, Marco F.
    Xu, Jin
    Liu, G. Frank
    Stek, Jon E.
    Boisnard, Florence
    Thomas, Stephane
    Ziani, Eddy
    Lee, Andrew W.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (02) : 209 - 215
  • [45] Association of CT antigen expression and survival in stage III melanoma.
    Turner, N. H.
    John, T.
    Deb, S.
    Campbell, A. M.
    Azad, A.
    Boutros, P. C.
    Chen, Y.
    Cebon, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage III/IV melanoma: A randomized, double-blind, phase 3 trial (CheckMate 238)
    Weber, J.
    Mandala, M.
    Del Vecchio, M.
    Gogas, H.
    Arance, A. M.
    Cowey, L. C.
    Dalle, S.
    Schenker, M.
    Chiarion-Sileni, V.
    Marquez-Rodas, I.
    Grob, J-J.
    Butler, M.
    Middleton, M. R.
    Maio, M.
    Atkinson, V.
    Queirolo, P.
    de Pril, V.
    Qureshi, A.
    Larkin, J.
    Ascierto, P. A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] The prospective, randomized, double-blind clinical trial in orthopaedic surgery
    Clark, CR
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1997, 79A (08): : 1119 - 1120
  • [48] Identification of novel tumor associated antigens in a cohort of patients undergoing an immunotherapeutic clinical trial for advanced stage melanoma.
    Bellows, BR
    Conry, RM
    Bonnet, MC
    LoBuglio, AF
    Strong, TV
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A118 - A118
  • [49] Reduction of postoperative pain: A double-blind, randomized clinical trial
    Browning, WD
    Johnson, WW
    Gregory, PN
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1997, 128 (12): : 1661 - 1667
  • [50] Lidocaine for systemic sclerosis: a double-blind randomized clinical trial
    Riera, Rachel
    Andrade, Luis E. C.
    Souza, Alexandre W. S.
    Kayser, Cristiane
    Yanagita, Edison T.
    Trevisani, Virginia F. M.
    ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
12345